BECTON DICKINSON CARIBE LTD. BD BACTEC¿ PLUS AEROBIC/F CULTURE VIALS (PLASTIC); SYSTEM, BLOOD CULTURING
|
Back to Search Results |
|
Model Number 442023 |
Device Problem
False Positive Result (1227)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 12/03/2021 |
Event Type
malfunction
|
Manufacturer Narrative
|
A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
|
|
Event Description
|
It was reported that while testing with the bd bactec¿ plus aerobic/f culture vials (plastic), one false positive result was obtained.Confirmatory subculture testing was performed.Erroneous results were not reported out, and there was no report of patient impact.The following information was provided by the initial reporter: 1 false positive bottle on 442023 lot 1245128 due to poor sensor adhesion.
|
|
Event Description
|
It was reported that while testing with the bd bactec¿ plus aerobic/f culture vials (plastic), one false positive result was obtained.Confirmatory subculture testing was performed.Erroneous results were not reported out, and there was no report of patient impact.The following information was provided by the initial reporter: 1 false positive bottle on 442023 lot 1245128 due to poor sensor adhesion.
|
|
Manufacturer Narrative
|
Investigation summary: customer reported a sensor adhesion defect.Photos were not received.Retention samples could not be visually inspected/ tested for reported defect.Batch history record review was used for this investigation.Batch/sensor history records were reviewed, and all testing were within specification for product release.A complaint history review was conducted and only the current complaint was found relating to the incident lot number and the ¿as reported¿ defect code.Sensor adhesion scrape test is performed to each sensor batch as part of release criteria.Complaint is unconfirmed.The vision system is challenged prior each lot.Product insert warnings and precautions sections states that prior to use, each vial should be examined for evidence of contamination such as cloudiness, bulging or depresses septum, or leakage.Vials showing evidence of contamination should not be used.Also prior to use, the user should examine the vial for evidence of damage or deterioration.Vials displaying turbidity, contamination, or discoloration (darkening) should not be used.Corrective actions preventive actions (capa) 2882676 was initiated to further investigate these types of complaints and determine any appropriate actions to reduce their occurrence.A cross functional team continually monitors all product complaints for trends and determines if any additional actions are necessary beyond the current investigational process.H3 other text : see h10.
|
|
Search Alerts/Recalls
|
|
|